Daniel J. Watson
11Patents
4h-index
24Co-inventors
60Inventor score
Filing activity: Jan 27, 1998 → Jul 29, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6091062A | Method and apparatus for temperature control of a semiconductor electrical-test contractor assembly | Physics | 510 | Expired |
| US9168254B2 | Polymorphs of ARRY-380, a selective HER 2 inhibitor and pharmaceutical compositions containing them | Chemistry; Metallurgy | 9 | Active |
| US9889134B2 | Polymorphs of ARRY-380, a selective HER 2 inhibitor and pharmaceutical compositions containing them | Chemistry; Metallurgy | 7 | Active |
| US10143692B2 | Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing them | Chemistry; Metallurgy | 6 | Active |
| US8044083B2 | Kinase inhibitors and methods of use thereof | Chemistry; Metallurgy | 4 | Active |
| US10765678B2 | Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing them | Chemistry; Metallurgy | 4 | Active |
| US8039639B2 | Kinase inhibitors and methods of use thereof | Chemistry; Metallurgy | 2 | Active |
| US10835533B2 | 1 -((3S,4R)-4-(3-fluorophenyl)-1-(2-methoxyethyl)pyrrolidin-3-yl)-3-(4-methyl-3-(2-methylpyrimidin-5-yl)-1-phenyl-1H-pyrazol-5-yl)urea as a TrkA kinase inhibitor | Emerging Cross-Sectional Technologies | 1 | Active |
| US11571424B2 | Polymorphs of ARRY-380, a selective HER2 inhibitor and pharmaceutical compositions containing them | Chemistry; Metallurgy | 0 | Active |
| US9790206B2 | Intermediates for use in the preparation of indazole derivatives and processes for the preparation thereof | Chemistry; Metallurgy | 0 | Active |
| US8461479B2 | Adaptive processing constraints for memory repair | Electricity | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.